PMMI ProSource – Start Your Search
Check out our packaging and processing solutions finder, PMMI ProSource.

Industry 4.0 with a pharma focus

Knowing that IoT software and services in pharma are expected to reach $2.5 billion by 2020, this builder of pharmaceutical packaging machinery is rolling out a robust Industry 4.0 program.

The line assembled by Marchesini to demonstrate its Industry 4.0 program consisted of three machines for primary, secondary, and tertiary packaging of pharmaceutical blister packs.
The line assembled by Marchesini to demonstrate its Industry 4.0 program consisted of three machines for primary, secondary, and tertiary packaging of pharmaceutical blister packs.

During a well-attended Open Factory April 10-12 at its Pianoro headquarters plant outside Bologna Italy, pharmaceutical packaging machinery specialist Marchesini Group officially unveiled its Industry 4.0 program.

Industry 4.0, of course, is the fourth industrial revolution, a transformation now underway where sensors, machines, and IT systems will be tightly integrated all along the value chain. These connected systems can interact with one another thanks to standardized Internet-based communications protocols. And by interacting with one another, they can analyze data to predict failure, reconfigure themselves, and adapt to changes. Industry 4.0, sometimes called the Internet of Things (IoT), will make it possible to gather and analyze data across machines, resulting in faster, more flexible, and more efficient manufacturing processes to produce higher-quality goods at a reduced cost.

Among several things made abundantly clear at the Marchesini event is that digitization, or the conversion of analog source material into a numerical format, is a critical first step on the road to Industry 4.0. It was even suggested that the very definition of Industry 4.0 might be this: digitization applied to manufacturing.

Why the emphasis on digitization? Here are two primary reasons. First, it means that information in a variety of formats can be collected and processed with the same efficiency. This is especially true in Marchesini’s case since the communications protocol the firm has adopted across the board is OPC Unified Architecture (OPC UA). It’s a machine-to-machine communications protocol for industrial automation that’s described as SOA (service-oriented architecture), a style of software design whose basic principles are independent of vendors, product, and technologies. Other distinguishing characteristics of OPC UA include these:

• it’s open and freely available

• it’s not tied to one operating system or programming language

• it’s robust from a security standpoint

A second benefit of digitization is that once processes are digitized, it opens the door to other exciting possibilities such as machine learning, condition monitoring, remote-access monitoring, and, ultimately, the smart factory. In the smart factory, operations are carried out with minimal manual intervention, high reliability, and maximum flexibility. The automated workflows, synchronization of assets, and improved tracking and scheduling in the smart factory lead to increased yield and quality along with reduced cost and waste.

Predictably enough, the pharmaceutical industry is anything but immune to the impact of IoT and Industry 4.0, trends that are transforming pharma manufacturing at a rapid pace. Data shared at the Open Factory indicated that IoT software and services in the pharmaceutical industry are expected to grow from $420 million in 2015 to $2.5 billion by 2020.

“In such an environment,” said Marchesini Business Development Manager Stefano Selvatici at the Open Factory, “we feel it’s our responsibility to contribute to this transformative process by playing a leading role in terms of technology and know-how. That’s why all new machines ordered from us from now on will be Industry 4.0-ready.”

Selvatici went on to explain that Marchesini’s approach to all of this is best understood by thinking of it in three layers arranged in the shape of a pyramid. At the base is the production line itself. “This remains the biggest asset of the plant, no questions asked,” said Selvatici. “What changes going forward is that all of our machines will be equipped with software and sensors and data analytics capabilities to elevate their performance potential and make them intelligent to the point of being semi-autonomous.”

Blister packaging line
The line assembled by Marchesini to demonstrate its Industry 4.0 program during the Open Factory consisted of three machines for primary, secondary, and tertiary packaging of pharmaceutical blister packs. Upstream was the Integra 320 blister packer with Valida infeed system—with five cameras to control shape, thickness, and color of the pills—as well as the HarleNIR system from SEA Vision. This is an inspection system that combines a standard vision system solution with Near Infrared Hyperspectral vision technology. Thanks to this integrated imaging technology, HarleNIR can distinguish products based on their active ingredients. So it’s one more QA tool that pharmaceutical manufacturers can use to rule out any opportunity for a wrong product to make its way into a blister pack. Labeling on the line was carried out by the BL-A420 CW, which included a complete solution for tracking, serializing, and labeling of cartons, giving a unique identity to each pharmaceutical product packed. And at the end of the line was a case packer fully equipped to complete the final aggregation of cartons with cases: the MC 820 TT.